. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Gastrointest Endosc. 2020 Jan 15;92(1):31–39.e1. doi: 10.1016/j.gie.2020.01.013

Table 1:

Baseline Demographics

	Surgical Group (N=68)	Endoscopic Group (N=73)	P value
Age, median (IQR)	64.1 (59.8, 71.9)	73.4 (65.8, 80.5)	<0.001
Male, n (%)	63 (92.6)	56 (76.7)	0.009
BMI (kg2/m), median (IQR)^*	29.3 (25.7, 32.3)	28.8 (24.9, 31.8)	0.595
Charlson Comorbidity Index, median (IQR)^§	4.0 (4.0, 6.0)	5.0 (4.0, 6.0)	0.060
Lymphovascular invasion, n (%)^♩	25 (37.9%)	20 (29.4%)	0.300
Well-moderately (G1/2) Differentiated, n (%)	44 (64.7%)	48 (65.8%)	0.896
EMR Deep Margin Positive, n (%)	41 (60.3%)	42 (57.5%)	0.739
Lymph node metastasis, n (%)	10 (14.7%)
Adjuvant Chemo-radiation, n (%)	5 (7.4%)	19 (26.0%)	0.003
BE segment length (cm), median (IQR)	3 (0, 6)	4 (2, 7)	0.027

BE = Barrett’s esophagus, BMI = body mass index, EMR = endoscopic mucosal resection, IQR = interquartile range

missing 10 in the endoscopic group and 3 in the surgical group

^§

missing in 2 in the endoscopic group

^♩

missing in 5 in the endoscopic group and 2 in the surgical group